Literature DB >> 16844847

Anticoagulation in ischaemic heart disease.

R De Cristofaro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16844847      PMCID： PMC1861107          DOI： 10.1136/hrt.2005.085555

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  7 in total

1.  Is warfarin a contraindication to thrombolysis in acute ST elevation myocardial infarction?

Authors:  A G Stanley; S Fletcher; A Tan; D B Barnett
Journal:  Heart       Date:  2006-08       Impact factor: 5.994

2.  Risks of oral anticoagulant therapy with increasing age.

Authors:  Marieke Torn; Ward L E M Bollen; Felix J M van der Meer; Ernst E van der Wall; Frits R Rosendaal
Journal:  Arch Intern Med       Date:  2005-07-11

3.  Impact of chronic oral anticoagulation on management and outcomes of patients with acute myocardial infarction: data from the RICO survey.

Authors:  A Oudot; P G Steg; N Danchin; G Dentan; M Zeller; P Sicard; P Buffet; Y Laurent; L Janin-Manificat; I L'Huillier; J C Beer; H Makki; P Morel; Y Cottin
Journal:  Heart       Date:  2005-12-30       Impact factor: 5.994

Review 4.  New anticoagulants.

Authors:  J I Weitz; S M Bates
Journal:  J Thromb Haemost       Date:  2005-08       Impact factor: 5.824

Review 5.  Antithrombotic therapy for coronary artery disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Authors:  Robert A Harrington; Richard C Becker; Michael Ezekowitz; Thomas W Meade; Christopher M O'Connor; David A Vorchheimer; Gordon H Guyatt
Journal:  Chest       Date:  2004-09       Impact factor: 9.410

6.  An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1993-09-02       Impact factor: 91.245

Review 7.  Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1994-02-05       Impact factor: 79.321
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.